Shanghai OPM Biosciences Co., Ltd. (SHA:688293)
China flag China · Delayed Price · Currency is CNY
63.45
+0.38 (0.60%)
At close: Nov 17, 2026

Shanghai OPM Biosciences Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
843.43787.45891.141,2821,506310.34
Short-Term Investments
30.65312.5386.1452.6440.0740.17
Trading Asset Securities
341.39246.73358.08148.75170.71-
Cash & Short-Term Investments
1,2151,3471,3351,4841,717350.51
Cash Growth
-11.37%0.85%-9.99%-13.57%389.76%13.37%
Accounts Receivable
273.45102.06110.8596.3576.8141.75
Other Receivables
14.33.68.57-8.04-
Receivables
287.75105.66119.4296.3584.8541.75
Inventory
201.4673.7959.1249.2144.0133.72
Prepaid Expenses
----10.55-
Other Current Assets
46.3238.4235.1830.1712.6615.2
Total Current Assets
1,7511,5651,5491,6591,869441.18
Property, Plant & Equipment
453.44329376.42296.92264.04142.83
Long-Term Investments
200.89258.08264.58239.73143.7368.09
Other Intangible Assets
78.9435.8237.6839.2140.3342.46
Long-Term Deferred Tax Assets
21.8710.473.582.080.840.13
Long-Term Deferred Charges
144.1847.0152.0660.321.5225.38
Other Long-Term Assets
588.551.652.844.438.5327
Total Assets
3,8222,2472,2862,3022,348747.08

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
61.2324.0962.837.4621.3113.75
Accrued Expenses
30.0126.3119.5818.0819.9115.66
Short-Term Debt
10---20.0240.04
Current Portion of Long-Term Debt
----4.312.13
Current Portion of Leases
190.8314.9213.028.66.455.27
Current Income Taxes Payable
12.0804.420.62-1.63
Current Unearned Revenue
112.276.5415.574.2816.0416.62
Other Current Liabilities
55.9954.031.61.210.72
Total Current Liabilities
472.476.86119.4270.6589.2695.82
Long-Term Debt
0.13---10.8617.77
Long-Term Leases
112.8642.0852.3260.7950.1556.51
Long-Term Unearned Revenue
32.2128.4217.8912.1812.5414.53
Long-Term Deferred Tax Liabilities
10.720.941.330.590.26-
Total Liabilities
780.09148.29190.97144.21163.07184.62

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
142.19113.82114.77114.7781.9861.49
Additional Paid-In Capital
2,7931,8651,9041,8991,925428.34
Retained Earnings
113.39121.45128.58158.7417872.63
Treasury Stock
---51-13.75--
Comprehensive Income & Other
-5.2-0.060.240.190.12-
Total Common Equity
3,0432,1002,0972,1592,185562.45
Minority Interest
-0.77-2.15-1.47-0.78--
Shareholders' Equity
3,0422,0982,0952,1582,185562.45
Total Liabilities & Equity
3,8222,2472,2862,3022,348747.08

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
313.825765.3469.3991.8121.72
Net Cash (Debt)
901.651,2901,2701,4141,625228.79
Net Cash Growth
-31.32%1.55%-10.20%-12.96%610.20%-16.88%
Net Cash Per Share
6.7711.4410.8612.3016.042.65
Filing Date Shares Outstanding
142.48113.82113.55113.91114.7786.08
Total Common Shares Outstanding
142.19113.82113.55114.53114.7786.08
Working Capital
1,2791,4881,4301,5891,780345.36
Book Value Per Share
21.4018.4518.4718.8519.036.53
Tangible Book Value
2,3812,0652,0592,1192,144519.99
Tangible Book Value Per Share
16.7418.1418.1318.5118.686.04
Buildings
-226.0963.863.863.827.17
Machinery
-239.06230.6200.88128.56112.33
Construction In Progress
-0.4169.3378.1103.471.31